🗳️ Last week to vote! » https://bit.ly/46V4v5I We're honored to be considered for the Society for Clinical Research Sites (SCRS) Eagle Award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships. We're grateful for the collaborative relationships with our site partners, and if you feel we have met these exceptional standards, we would be humbled to receive your vote for best CRO.
PPD
Mga Serbisyo sa Pananaliksik
Wilmington, NC 584,502 tagasubaybay
Helping deliver life-changing therapies
Tungkol sa amin
PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
- Website
-
https://www.ppd.com
External na link para sa PPD
- Industriya
- Mga Serbisyo sa Pananaliksik
- Laki ng kompanya
- 10,001+ na mga empleyado
- Headquarters
- Wilmington, NC
- Uri
- Pampublikong Kompanya
- Mga Specialty
- clinical research, drug development, CRO, patient recruitment, laboratory, pharmaceutical, biotechnology, biopharma, biopharmaceutical, consulting, therapeutics, Functional Service Partnerships, consulting, Early Development, Post-Approval, medical writing, drug information, pharmacovigilance, biostatistics, bioanalytical
Mga Lokasyon
Mga empleyado sa PPD
Mga update
-
Ni-repost ito ni PPD
For years, clinical trials have not accurately reflected the diversity within our population, leading to inequities in healthcare and scientific research. Yesterday, we hosted a Congressional briefing with industry leaders and patient advocates dedicated to bridging the gap for a more equitable future in science. Thank you to our panelists: Thermo Fisher Scientific’s Dr. Rose Blackburne, MD, MBA, Vice President, Medical Science and Strategy, and Global Head of General Medicine and Women’s Health, Vanderbilt University Medical Center’s Dr. Sheila Kusnoor, National Minority Quality Forum’s Dr. Salvatore (Salvo) Alesci and Cystic Fibrosis Foundation’s Ashleigh Tharp. Cross-industry collaboration is essential to support scientific discovery and understand how we can better connect communities to ongoing research and treatment discovery.
-
-
#AAIC24 begins on Sunday! Join us for discussion on the latest topics in #Alzheimers #drugdevelopment and meet our team at booth 920. Stephen J. Peroutka, M.D., Ph.D will present a poster on Wednesday examining comorbidity profiles of younger vs older individuals with or without Alzheimer’s – don’t miss it! It’s not too late to book a meeting. » https://bit.ly/3y0K3DP
-
-
In early #clinicaldevelopment, transparency around the research question of interest – the #estimand – is key. An estimand is a precise description of the treatment effect to be summarized in your research. From this white paper you'll learn why they're relevant in #clinicalpharmacology trials, key steps in the estimand thinking process, how they aid in clarifying R&D goals, and their growing use in #clinicaltrial protocols following new #regulatoryguidance. » https://bit.ly/3A6yJqd
-
-
Decentralized clinical trials (DCTs) have the potential to improve patient enrollment and diversity through patient-centric study design leveraging digital technology. Keri Henderson explores more in American Pharmaceutical Review. 📝 » https://bit.ly/4fbuYQJ
Analyzing the Influence of Key Factors for Patient Willingness to Participate in Decentralized Clinical Trials
ppd.com
-
Medical monitoring is a vital part of every pediatric clinical trial. Our primary goal is to safeguard the health and interests of all participating children, considering their unique ages and developmental stages. Anu Ohrling, MD MBA delves into how our skilled team of pediatricians employs a comprehensive and multidisciplinary approach to help ensure the safety and well-being of every child participating in a #clinicaltrial. » https://bit.ly/44vKXEd
-
Looking to scale up your #cellandgenetherapy #clinicaltrial? We have the therapeutic expertise to elevate your research to new heights. We bring extensive experience in efficiently managing large-scale trials, optimizing processes and ensuring regulatory compliance every step of the way. Our expertise in logistics, data management and patient recruitment streamlines operations, enabling seamless expansion while maintaining quality and safety standards. Learn more about how we can support your cell and gene therapy research. » https://bit.ly/3V8YOOd
-
-
Ni-repost ito ni PPD
“Early on, [focus on] understanding what’s important to patients and their families so that they stay engaged with the trial, what’s important to the sites in terms of how to arrange the day to be less burdensome, and then how to really understand what’s clinically meaningful to the patients and their parents from a protocol perspective.” In the latest episode of ACRO’s Good Clinical Podcast, Susan McCune, MD, VP, Pediatrics & Clinical Pharmacology, PPD and Jacqui Whiteway, Senior Director & Pediatric Strategy Liaison, Center for Pediatric Clinical Development, ICON plc, discuss what makes pediatric clinical trials unique and how industry can make participation easier for pediatric patients and their families. Listen to the full episode: https://lnkd.in/gdMz_agR
-
Seeking to develop #neurodegenerative disorder treatments? Partner with our experienced #clinicalresearch team, equipped with operational and medical expertise across multiple indications, to explore novel approaches like #decentralizedtrials and clinical trial simulations. » https://bit.ly/3xyIXOQ
-
-
"This new building was purpose-built with our specific lab needs in mind, and the work performed here in Middleton will continue to have a major impact on the future of clinical research and development." We recently cut the ribbon on a new facility at our GMP laboratory in Middleton, Wisconsin, an expansion that enhances our analytical capabilities through high quality scientific expertise and industry-leading technologies to help our customers bring safe, effective medicines to patients. 📰 » https://bit.ly/4fnW1IH